Pharmacological treatment of early multiple sclerosis (Q37032558)

17 August 2017

1 reference

title

Pharmacological treatment of early multiple sclerosis (English)

1 reference

17 August 2017

0 references

1 reference

13

Hans-Peter Hartung

1 reference

17 August 2017

1

Olaf Stüve

1 reference

17 August 2017

14

Bernd C Kieseier

1 reference

17 August 2017

4

Heinz Wiendl

1 reference

17 August 2017

8

Robert Zivadinov

1 reference

17 August 2017

6

Amit Bar-Or

1 reference

17 August 2017

Jeffrey L Bennett

2

1 reference

17 August 2017

Bernhard Hemmer

3

1 reference

17 August 2017

Michael K Racke

5

1 reference

17 August 2017

Wei Hu

7

1 reference

17 August 2017

Martin S Weber

9

1 reference

17 August 2017

Scott S Zamvil

10

1 reference

17 August 2017

Maria F Pacheco

11

1 reference

17 August 2017

Til Menge

12

1 reference

17 August 2017

Elliot M Frohman

15

1 reference

17 August 2017

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

68

1 reference

17 August 2017

73-83

1 reference

17 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200868010-00005

17 August 2017

0 references

cites work

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes

1 reference

12 December 2020

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

1 reference

12 December 2020

MRI findings in benign multiple sclerosis are variable.

1 reference

12 December 2020

Longitudinal follow-up of "benign" multiple sclerosis at 20 years

1 reference

12 December 2020

British Isles survey of multiple sclerosis in twins: MRI.

1 reference

12 December 2020

Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.

1 reference

12 December 2020

1 reference

12 December 2020

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Survival and mortality rates among Danes with MS.

1 reference

12 December 2020

Optical coherence tomography in multiple sclerosis

1 reference

12 December 2020

Validation of the functional assessment of multiple sclerosis quality of life instrument

1 reference

12 December 2020

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis

1 reference

12 December 2020

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

1 reference

12 December 2020

Approved and future pharmacotherapy for multiple sclerosis

1 reference

12 December 2020

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

12 December 2020

Silent brain lesions in patients with isolated idiopathic optic neuritis. A clinical and nuclear magnetic resonance imaging study.

1 reference

12 December 2020

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

12 December 2020

Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis

1 reference

12 December 2020

New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes

1 reference

12 December 2020

Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS.

1 reference

12 December 2020

Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.

1 reference

12 December 2020

Disseminated lesions at presentation in patients with optic neuritis

1 reference

12 December 2020

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

1 reference

12 December 2020

Effect of relapses on development of residual deficit in multiple sclerosis

1 reference

12 December 2020

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

12 December 2020

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

12 December 2020

Magnetic resonance imaging in isolated noncompressive spinal cord syndromes.

1 reference

12 December 2020

Relapses and progression of disability in multiple sclerosis

1 reference

12 December 2020

Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

12 December 2020

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

1 reference

12 December 2020

Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis.

1 reference

12 December 2020

The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.

1 reference

12 December 2020

Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis

1 reference

12 December 2020

Neuronal cell injury precedes brain atrophy in multiple sclerosis

1 reference

12 December 2020

Natural history of multiple sclerosis

1 reference

12 December 2020

Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.

1 reference

12 December 2020

Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study.

1 reference

12 December 2020

MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis

1 reference

12 December 2020

Liver injury associated with the beta-interferons for MS.

1 reference

12 December 2020

Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis.

1 reference

12 December 2020

Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up

1 reference

12 December 2020

Oligoclonal bands in CSF: twins with MS

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

1 reference

12 December 2020

Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

12 December 2020

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study

1 reference

12 December 2020

An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS

1 reference

12 December 2020

Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study

1 reference

12 December 2020

Genetic epidemiology of multiple sclerosis: a survey

1 reference

12 December 2020

Magnetization transfer imaging to monitor the evolution of MS: A 1-year follow-up study

1 reference

12 December 2020

Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype.

1 reference

12 December 2020

Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis

1 reference

12 December 2020

Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

12 December 2020

Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome.

1 reference

12 December 2020

Long‐term follow‐up of acute partial transverse myelopathy

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

1 reference

12 December 2020

IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event

1 reference

12 December 2020

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

12 December 2020

Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis

1 reference

12 December 2020

A conventional and magnetization transfer MRI study of the cervical cord in patients with MS

1 reference

12 December 2020

Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota

1 reference

12 December 2020

Life expectancy in patients attending multiple sclerosis clinics

1 reference

12 December 2020

Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.

1 reference

12 December 2020

Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation

1 reference

12 December 2020

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis.

1 reference

12 December 2020

Origin of abnormal magnetic resonance imaging signal in multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. French Research Group on Multiple Sclerosis

1 reference

12 December 2020

Central nervous system atrophy and clinical status in multiple sclerosis

1 reference

12 December 2020

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.

1 reference

12 December 2020

10.2165/00003495-200868010-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference